With the knowledge and skills he gained providing strategic advice to boards and senior executives globally on the impact of digital disruption and innovation, John is instrumental in Artrya’s pursuit to help save lives faster.
As the company’s Co-Founder, John leads the clinical and commercial development of Artrya’s ground-breaking, non-invasive technology that will transform heart disease diagnosis.
Previously, John was the Global Industry Leader for Electronics at IBM, where he advised executives from some of the world’s largest corporations on product commercialization, strategy, digital transformation and enabling growth in markets such as Asia, the US and Europe.
He was a member of IBM’s Global Industry Academy and was recognized as a top Industry Executive in IBM. In this role, John was primarily responsible for defining the global industry strategy for IBM’s Electronics Industry segment. John currently serves on the Faculty Advisory Council for Engineering and Science at Curtin University. He holds an engineering degree from the University of Technology, Pretoria, and an IBM certification in Management Consulting.